Renaissance BioScience Corp., a global leader in yeast bioengineering, has announced the appointment of Dr. James Tansey to its Board of Directors. Dr. Tansey brings a wealth of experience as a serial entrepreneur, research academic, and business leader, with a strong background in life sciences, technology commercialization, fundraising, and corporate governance. His appointment is expected to bolster Renaissance's strategic direction as the company continues to develop and commercialize its innovative biotechnology platforms.
Dr. Tansey is a Professor at the University of British Columbia's Sauder School of Business and has previously served as a faculty member at Oxford University's Saïd Business School. He is also a member of the founding team at Gemina Labs, where he supports fundraising, business development, and shareholder strategy. Additionally, he serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd., and is a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund. His focus on impact investing and environmental sustainability aligns closely with Renaissance's mission to address environmental and industrial challenges through yeast-derived solutions.
Renaissance specializes in yeast bioengineering, with technology platforms centered on yeast-produced RNA and yeast-derived virus-like particles (VLPs). These platforms have initial applications in crop protection and future potential in animal and human health. The company's technologies aim to provide cost-effective, innovative solutions for agriculture, food, nutrition, and health sectors. Dr. Tansey's expertise in helping innovative technology companies grow and commercialize their products is seen as a valuable asset for Renaissance as it expands its global footprint.
Maurice Boucher, Renaissance Co-Founder and Executive Chairman, expressed enthusiasm about the appointment, stating: "James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow. James has consistently focused on 'Impact Investing' and environmental protection and sustainability throughout his exceptional career, which fits well with the positive environmental impact of Renaissance's technology platforms."
Dr. Tansey commented on his new role: "Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value." Dr. John Husnik, Renaissance Co-Founder, Director and CSO, added: "We are excited to welcome Dr. Tansey to our board. His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms."
The appointment signals Renaissance's commitment to strengthening its governance and strategic capabilities as it advances its yeast bioengineering platforms toward broader commercial applications. With Dr. Tansey's guidance, the company is poised to enhance its impact in sustainable agriculture and health solutions, potentially benefiting industries and consumers worldwide. For more information, visit www.renaissancebioscience.com.
